News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,297 Results
Type
Article (3158)
Company Profile (21)
Press Release (96117)
Section
Business (38781)
Career Advice (65)
Deals (5972)
Drug Delivery (13)
Drug Development (11600)
Employer Resources (8)
FDA (2098)
Job Trends (2401)
News (56224)
Policy (3427)
Tag
Academia (289)
Accelerated approval (15)
Adcomms (2)
Allergies (53)
Alliances (3563)
ALS (34)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (102)
Approvals (2322)
Artificial intelligence (78)
Autoimmune disease (85)
Automation (7)
Bankruptcy (17)
Best Places to Work (2202)
Biosimilars (30)
Biotechnology (16)
Bladder cancer (57)
Brain cancer (14)
Breast cancer (217)
Cancer (1440)
Cardiovascular disease (86)
Career advice (64)
Career pathing (5)
CAR-T (50)
CDC (4)
Celiac Disease (1)
Cell therapy (134)
Cervical cancer (9)
Clinical research (11748)
Collaboration (301)
Compensation (387)
Complete response letters (14)
COVID-19 (249)
CRISPR (22)
C-suite (205)
Cystic fibrosis (34)
Data (2195)
Depression (52)
Dermatology (23)
Diabetes (112)
Diagnostics (974)
Digital health (14)
Diversity, equity & inclusion (1)
Drug discovery (54)
Drug pricing (13)
Drug shortages (3)
Duchenne muscular dystrophy (73)
Earnings (35432)
Editorial (10)
Employer branding (2)
Employer resources (7)
Events (12916)
Executive appointments (91)
FDA (3119)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (226)
Gene editing (39)
Generative AI (6)
Gene therapy (110)
GLP-1 (175)
Government (463)
Grass and pollen (1)
Guidances (300)
Healthcare (2876)
HIV (22)
Huntington's disease (10)
IgA nephropathy (27)
Immunology and inflammation (48)
Immuno-oncology (25)
Indications (78)
Infectious disease (315)
Inflammatory bowel disease (38)
Inflation Reduction Act (1)
Influenza (22)
Intellectual property (55)
Interviews (9)
IPO (4274)
IRA (3)
Job creations (301)
Job search strategy (53)
JPM (2)
Kidney cancer (7)
Labor market (23)
Layoffs (69)
Leadership (3)
Legal (575)
Liver cancer (18)
Longevity (7)
Lung cancer (185)
Lymphoma (179)
Machine learning (4)
Management (2)
Manufacturing (139)
MASH (42)
Medical device (2241)
Medtech (2274)
Mergers & acquisitions (1938)
Metabolic disorders (278)
mRNA (17)
Multiple sclerosis (52)
NASH (3)
Neurodegenerative disease (77)
Neuropsychiatric disorders (20)
Neuroscience (619)
NextGen: Class of 2026 (800)
Non-profit (396)
Now hiring (6)
Obesity (114)
Opinion (8)
Ovarian cancer (54)
Pain (53)
Pancreatic cancer (76)
Parkinson's disease (97)
Partnered (1)
Patents (98)
Patient recruitment (166)
Peanut (16)
People (3502)
Pharmaceutical (7)
Pharmacy benefit managers (6)
Phase 1 (2871)
Phase 2 (4809)
Phase 3 (4926)
Pipeline (3724)
Policy (8)
Postmarket research (441)
Preclinical (805)
Press Release (1)
Prostate cancer (75)
Psychedelics (4)
Radiopharmaceuticals (65)
Rare diseases (224)
Real estate (388)
Recruiting (3)
Regulatory (3454)
Reports (15)
Research institute (228)
Resumes & cover letters (4)
Rett syndrome (8)
RNA editing (4)
RSV (24)
Schizophrenia (37)
Series A (38)
Series B (28)
Service/supplier (2)
Sickle cell disease (24)
Special edition (8)
Spinal muscular atrophy (57)
Sponsored (2)
Startups (268)
Stomach cancer (3)
Supply chain (13)
Tariffs (2)
The Weekly (4)
Vaccines (133)
Venture capital (16)
Weight loss (56)
Women's health (24)
Worklife (6)
Date
Last 7 days (346)
Last 30 days (1455)
Last 365 days (9477)
2026 (4620)
2025 (6385)
2024 (6124)
2023 (6916)
2022 (8318)
2021 (8139)
2020 (8155)
2019 (6925)
2018 (5075)
2017 (4621)
2016 (3831)
2015 (4367)
2014 (3197)
2013 (2087)
2012 (2497)
2011 (2731)
2010 (2789)
Location
Africa (75)
Alabama (45)
Alaska (1)
Arizona (62)
Asia (5593)
Australia (998)
California (3015)
Canada (729)
China (229)
Colorado (127)
Connecticut (122)
Delaware (116)
Europe (15833)
Florida (512)
Georgia (105)
Hawaii (1)
Idaho (8)
Illinois (189)
India (13)
Indiana (157)
Iowa (6)
Japan (163)
Kansas (19)
Kentucky (11)
Louisiana (12)
Maine (24)
Maryland (311)
Massachusetts (2290)
Michigan (62)
Minnesota (162)
Missouri (24)
Montana (3)
Nebraska (2)
Nevada (23)
New Hampshire (18)
New Jersey (907)
New York (812)
North Carolina (357)
North Dakota (1)
Northern California (1677)
Ohio (67)
Oklahoma (1)
Oregon (3)
Pennsylvania (620)
Puerto Rico (2)
South America (115)
South Carolina (16)
Southern California (1201)
Tennessee (43)
Texas (484)
United States (10791)
Utah (76)
Virginia (45)
Washington D.C. (3)
Washington State (259)
Wisconsin (16)
99,297 Results for "32".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Feinstein Institutes Awarded $3.2M Grant to Advance Polygenic Embryo Selection Research
October 23, 2025
·
3 min read
Mergers & acquisitions
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
Merck had previously offered anywhere from $28 billion to $32 billion to swallow Revolution Medicines.
January 26, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
September 25, 2025
·
3 min read
Weight loss
Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar
Zealand Pharma’s shares fell 32% in early morning trading Friday after its Roche-partnered asset petrelintide failed to meet investor expectations in a mid-stage clinical trial.
March 6, 2026
·
3 min read
·
Tristan Manalac
Press Releases
JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
October 1, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
November 3, 2025
·
4 min read
Press Releases
Immuno-Oncology Drugs Market Forecast to Hit USD 32.32 Billion in 2025 Amid Rising Cancer Incidence
June 18, 2025
·
1 min read
Press Releases
Shape Therapeutics Announces Multiple Oral Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress
September 29, 2025
·
1 min read
Press Releases
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress
September 29, 2025
·
1 min read
Press Releases
Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress
October 1, 2025
·
3 min read
Previous
2 of 9,930
Next
